Nikkei 225
28.042,88 +259,95 (+0,94%) Dow Jones 30
32.859,03 +141,43 (+0,43%) Bitcoin EUR
25.775,27 -168,74 (-0,65%) CMC Crypto 200
614,69 -4,55 (-0,73%) Nasdaq Compositive
12.013,47 +87,24 (+0,73%) S&P 500
4.050,83 +23,02 (+0,57%)
Gilead Sciences, Inc. (GIS.F)
- ACCESSWIRE
Gilead Sciences: A Career Rooted in Championing Diversity and Inclusion: Jesse's Story
NORHAMPTON, MA / ACCESSWIRE / November 10, 2022 / Gilead Sciences While Jesse Garcia was growing up in Chicago's inner city, his parents didn't immediately turn to a doctor when someone in the family got sick. "We relied on traditional Latino ...
- ACCESSWIRE
Gilead's Path to Equitable Global COVID-19 Treatment Access
NORTHAMPTON, MA / ACCESSWIRE / November 2, 2022 / Gilead Sciences Since the beginning of the COVID-19 pandemic, Gilead's first-in-class antiviral was made available to more than 11 million patients globally- over 65% of whom live in low-and lower-middle-income ...
- ACCESSWIRE
Gilead Sciences: Metastatic Breast Cancer Advocate Urges Black People to Join Clinical Trials
In the spring of 2018, North Carolina native Stephanie Walker went to her first breast cancer conference and had a revelation that she refers to as her "coming-out party." She learned she had metastatic breast cancer three years earlier and although she was a retired hospice nurse, she faced the disease without any guidance from others who shared her experience.
